As a leader specializing in medical weight loss, Red Mountain Weight Loss® patients get the most advanced and effective solutions to help them reach their goals. We’re excited to offer our newest formulation of our signature Revolex™ medication: Revolex TRZ™ with tirzepatide. Here are four things you should know about tirzepatide:
FDA-Approved for Weight Management
Tirzepatide is an ingredient in diabetes medication that the FDA approved to treat obesity in November 2023. Initial clinical trials have shown tirzepatide to be effective in helping people both with and without diabetes lose weight. Some patients lost up to 20% of their overall body weight in a 17-month study.
Results Are Seen Quickly
After your first dose, you should begin experiencing weight loss within the first few weeks. However, everyone’s weight loss journey is different, and how much weight you lose will be determined by how closely you stick to your individualized Flex™ diet plan and other inherited factors, such as genetics.
Mimics 2 Gut Hormones
Tirzepatide mimics GLP-1, which is involved in blood sugar control and digestion. It also acts on a second hormone called GIP to inhibit caloric intake and stimulate satiety (fullness). With GLP-1 and GIP working together, tirzepatide may offer patients enhanced weight loss results.
Should Be Used With Healthy Lifestyle Changes
Tirzepatide is best combined with other healthy lifestyle modifications to achieve and maintain your results long-term. That is why we prescribe Revolex TRZ™ as part of our Flex with Revolex™ weight loss program to help you lose up to 15 lbs. or more per month.
Now Available: Revolex TRZ™ with Tirzepatide
- Our proprietary, full-strength tirzepatide medication.
- Tirzepatide is FDA-approved for weight management.
- Lose up to 15 lbs. or more per month with our Flex with Revolex™ weight loss program.
We are here to support you as you take the first step on your weight loss journey toward a healthier and happier you. Book an appointment to find out if Revolex TRZ is right for you.